Small Bowel Adenocarcinoma: From Molecular Insights to Clinical Management
Open Access
- 17 February 2022
- journal article
- research article
- Published by MDPI AG in Current Oncology
- Vol. 29 (2) , 1223-1236
Abstract
Small bowel adenocarcinoma (SBA) is a rare malignancy, with a rising incidence in recent decades, and accounts for roughly 40% of all cancers of the small bowel. The majority of SBAs arise in the duodenum and are associated with a dismal prognosis. Surgery remains the mainstay of treatment for localized disease, while systemic treatments parallel those used in colorectal cancer (CRC), both in the adjuvant and palliative setting. In fact, owing to the lack of prospective data supporting its optimal management, SBA has historically been treated in the same way as CRC. However, recent genetic and molecular data suggest a distinct profile from other gastrointestinal malignancies and support a more nuanced approach to its management. Herein, we briefly review the state-of-the-art in the clinical management of early-stage and advanced disease and recent discoveries of potentially actionable genetic alterations or pathways along with the most promising ongoing clinical trials, which will hopefully revolutionize the treatment landscape of this orphan disease in the foreseeable future.Keywords
This publication has 89 references indexed in Scilit:
- A Population-Based Comparison of Adenocarcinoma of the Large and Small Intestine: Insights Into a Rare DiseaseAnnals of Surgical Oncology, 2011
- Second‐line chemotherapy with fluorouracil, leucovorin, and irinotecan (FOLFIRI regimen) in patients with advanced small bowel adenocarcinoma after failure of first‐line platinum‐based chemotherapyCancer, 2010
- A Comparative Study of Complete Cytoreductive Surgery Plus Intraperitoneal Chemotherapy to Treat Peritoneal Dissemination From Colon, Rectum, Small Bowel, and Nonpseudomyxoma AppendixAnnals of Surgery, 2010
- Chemotherapy of advanced small-bowel adenocarcinoma: a multicenter AGEO studyAnnals of Oncology, 2010
- Is there a role for adjuvant therapy in resected adenocarcinoma of the small intestineActa Oncologica, 2010
- Hepatic Resection for Noncolorectal Nonendocrine Liver MetastasesTransactions of the ... Meeting of the American Surgical Association, 2006
- Immunohistochemical investigation of tumorigenic pathways in small intestinal adenocarcinoma: a comparison with colorectal adenocarcinomaLaboratory Investigation, 2006
- Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis from small bowel adenocarcinomaJournal of Surgical Oncology, 2005
- Mucinous adenocarcinoma of the small bowel with peritoneal seedingEuropean Journal of Surgical Oncology, 2002
- DOES BILE PROMOTE EXTRA-COLONIC CANCER?The Lancet, 1978